Therapeutic mechanism of Polygonum multiflorum Thunb. in premature ovarian insufficiency: an integration of network pharmacology, molecular docking, and experimental validation
Journal of the Science of Food and Agriculture · 2026-06 · 106 (8) · 4666-4677
DOI: 10.1002/jsfa.70545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, online erschienen am 10.03.2026. Verfasst von Jinhong Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Chinese Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Fallopia multiflora, Plant Extracts. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Premature ovarian insufficiency (POI) often leads to infertility and long‐term health complications. Processed Polygonum multiflorum Thunb. (PM) is a traditional medicinal and edible plant widely used in health supplements and herbal medicine. It has shown potential in mitigating ovarian aging but its mechanisms against POI remain unclear. RESULTS This study integrated network pharmacology, molecular docking, and experimental validation to explore the therapeutic mechanism of PM in POI. Bioactive compounds in PM were identified by liquid chromatography–mass spectrometry and literature screening, yielding 91 compounds targeting 320 POI‐related genes. Core targets included AKT1, PIK3CA, and PIK3R1 , with pathway enrichment highlighting the PI3K/AKT signaling pathway, which was further supported by molecular docking. In a rat model of POI, treatment with either low‐ or high‐dose PM restored estrous cyclicity, improved serum follicle‐stimulating hormone (FSH) and estradiol (E 2 ) levels, improved follicular development, and increased the expression of bone morphogenetic protein 15 (BMP‐15), growth differentiation factor 9 (GDF‐9), and key PI3K/AKT proteins. CONCLUSION Polygonum multiflorum Thunb. may alleviate POI by activating the PI3K/AKT pathway, restoring hormonal balance, reducing follicular atresia, and preserving ovarian reserve. These findings underscore the potential of PM as a natural therapeutic resource for POI management. © 2026 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Chinese Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- College of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
ORCID-Profile: Can Zhu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Liu, Y., You, H., Li, S., Lin, C., & Zhu, C. (2026). Therapeutic mechanism of Polygonum multiflorum Thunb. in premature ovarian insufficiency: an integration of network pharmacology, molecular docking, and experimental validation. Journal of the Science of Food and Agriculture, 106(8), 4666-4677. https://doi.org/10.1002/jsfa.70545
Vancouver
Li J, Liu Y, You H, Li S, Lin C, Zhu C. Therapeutic mechanism of Polygonum multiflorum Thunb. in premature ovarian insufficiency: an integration of network pharmacology, molecular docking, and experimental validation. Journal of the Science of Food and Agriculture. 2026;106(8):4666-4677. doi:10.1002/jsfa.70545
BibTeX
@article{Li2026,
author = {Li, Jinhong and Liu, Yang and You, Haoling and Li, Song and Lin, Chang and Zhu, Can},
title = {Therapeutic mechanism of Polygonum multiflorum Thunb. in premature ovarian insufficiency: an integration of network pharmacology, molecular docking, and experimental validation},
journal = {Journal of the Science of Food and Agriculture},
year = {2026},
volume = {106},
number = {8},
pages = {4666--4677},
doi = {10.1002/jsfa.70545}
}
EUVIMED